                         SEQUENCE LISTING

<110>  ACTELION PHARMACEUTICALS LTD
 
<120>  Peptides as modulators of FPRL1 and/or FPRL2

<130>  Act 214A

<160>  14    

<170>  PatentIn version 3.3

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  1

Trp Pro Pro Leu Arg Ala His Leu Leu Thr Tyr Gln 
1               5                   10          


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  2

Leu Pro Ser Arg Tyr Asn Leu Asn Leu Leu Thr Tyr 
1               5                   10          


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  3

Tyr Leu Lys Pro His Lys Ser Leu His Leu Leu Thr 
1               5                   10          


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  4

Phe Pro Thr Leu Asn Pro Ile Leu Leu Thr Tyr Ser 
1               5                   10          


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  5

Trp Ser Pro Ser Arg Pro Gly Leu Pro Leu Leu Ile 
1               5                   10          


<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  6

Trp Pro Leu Pro Lys Leu Ala Thr Ser Gly Ile Leu 
1               5                   10          


<210>  7
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  7

Leu Ala Pro Asn Arg Pro Met Leu Glu Leu Leu Thr 
1               5                   10          


<210>  8
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  8

Phe Pro Tyr His Val Ala Ala Met Arg His Thr Leu 
1               5                   10          


<210>  9
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  9

Ser Pro Gln Phe Ser His Val Leu Arg Leu Gly Leu 
1               5                   10          


<210>  10
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  10

Asn His Arg Leu Pro Leu Pro Ala Leu Leu Trp 
1               5                   10      


<210>  11
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  11

Trp Ser Phe Gly Asn Pro Gly Leu Leu Phe Ser Ile 
1               5                   10          


<210>  12
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  12

Ile Leu Ala Asn Val Leu Thr Ala Pro Gly Pro Arg 
1               5                   10          


<210>  13
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  13

His Met Trp Asn Pro Gly Ile Ile Tyr Ser Ile Lys 
1               5                   10          


<210>  14
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  14

Ile Pro Ile Ser Arg Glu Leu Val Thr His Asp Pro 
1               5                   10          


